About this trial
The purpose of this study is to determine the feasibility, acceptability, efficacy, and participant adherence in using home-based technologies and wearable devices and simple, practical strategies to reduce the negative impact that evening screen time may have on your health.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
≥26 years of age
BMI ≥ 27 kg/m2*; ≥25 kg/m2, if Asian (full or multiple race)**
Insufficiently active (per US National Guidelines for Physical Activity of 150 minutes of MVPA/Week)
Reporting an average of ≥3 hours of recreational sedentary screen time (rSST) per day, that usually extends at least until 9:00pm.
Disqualifiers
Conditions related to sleep disruption, including lactation, pregnancy, mid-night care providers, sleep disorders, severe sleep apnea
History of hypoglycemia
Pacemaker
Caffeine consumption in excess and/or after 5pm (excess equals >4 cups of coffee per day or equivalent)
Trial design
Crossover
Treatments tested in this trial
Blue light
BehavioralBlue light blocking glasses use and discouraged late night eating.
Eating
BehavioralEncouraged not to eat past 8pm.
Standing
BehavioralEncouraged to stand for 10 minutes per hour each out from 5pm to bed time.
Treatment groups
6
Treatment groupsSee each treatment group below.
Trial outcomes
Primary outcomes
Treatment acceptability
Intervention acceptability will be assessed using the Treatment Evaluation Questionnaire (TEQ) to measure acceptability of the three experimental conditions following the completion of each condition. Scale Range: 0 to 4. Higher scores indicate greater acceptability.
Changes in Evening Sedentary Screen Time
Minutes per week of screen time after 5p as measured by WatchWell app and activPAL
Change in evening postprandial glycemic control (5pm - 5am)
Participants will be asked to wear the Dexcom G6 Pro continuous glucose monitor during baseline and experimental conditions. Glycemic control will be calculated by averaging all glucose readings from 5pm - 5am during each of the conditions.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.